HEalth & Life sciences

Pathogen Program

Transforming how the world understands and responds to infectious disease
Working to develop the science that equips lab teams to take swift, informed action to counteract these threats.
Pathogen Program CEO

Dr Emma Stanton

“We have an extraordinary opportunity at EIT to deploy new technologies and new scientific breakthroughs at an accelerated pace to transform healthcare globally."
Click to play video of Pathogen Program CEO Emma Stanton and Principal Scientist Gil McVean
Preventing the next pandemic

Delivering high-confidence insights from pathogen sequencing

The challenge

We need to fundamentally reimagine infectious disease management

Antimicrobial resistance

Pathogens are constantly shifting, developing new resistance patterns and spreading in unpredictable ways. Accelerating factors such as antibiotic overuse and misuse, and poor infection control are increasing the prevalence of AMR.

Fragmentation

The current infrastructure to monitor pathogens is fragmented and doesn’t cover more than a few types of pathogens.

Lack of high-quality data

Public health decision making is often based on outdated data, and diagnosing infectious diseases largely remains a matter of interpretation for clinicians.

Need for multidisciplinary approach

Complex problems demand the combined expertise of scientists, clinicians, engineers, and data specialists working together. Only through collective innovation can we translate discovery into real-world impact.

7mCOVID-19 global deaths

COVID-19 has claimed the lives of seven million people worldwide.

27.5%chance of another pandemic

There’s a 27.5% probability of another pandemic as deadly as COVID-19 within the next ten years.

39mpotential deaths

Antimicrobial resistance could cause an additional 39 million deaths between 2025 and 2050.

our approach

Create deep understanding of pathogen behaviour

The Pathogen Program is pioneering next generation digital pathology labs that deliver high-confidence insights: identifying pathogens, detecting resistance and tracking outbreaks with precision and speed.

Better data

We need a global system of connected point-of-care, pathogen-agnostic diagnostic devices able to identifying pathogens, detecting resistance and tracking outbreaks with precision and speed.

Better diagnostics

We need to move from a focus on phenotype-based testing to genotype-based diagnostics, which can identify disease-causing pathogens with greater speed and accuracy.

Better detection

We need to shift attitudes towards an ‘Always On’ mindset that is supported by a monitoring system that dramatically increases our ability to detect epidemics and pandemics early, globally.

Better collaboration

We need the combined expertise of microbiologists, clinicians, data scientists, engineers and robotics specialists, working together to transform complex scientific discovery into real-world solutions that strengthen our ability to prevent and respond to infectious threats.

Learn more

To learn more about the Pathogen Program's mission and products, visit their website .

team

The Pathogen Program brings together scientists, academics, medical practitioners and more

Chief Executive Officer of the Pathogen Program

Dr Emma Stanton

Dr Emma Stanton is Chief Executive of the Pathogen Program, EIT’s first flagship program focused on global infectious disease detection and prevention. She was previously SVP Clinical and Head of Diagnostics at Oxford Nanopore Technologies.

Principal Scientist

Professor Gil McVean

Principal Scientist of the EIT Pathogen Program. Professor of Statistical Genetics at the Department of Statistics and the Nuffield Department of Medicine, University of Oxford.

Join our team

We’re gathering the greatest minds

EIT is growing rapidly and we are recruiting at pace. Thrive in a dynamic and fast-paced work environment, learning and growing every day alongside experts in science and technology.